Main Menu

On July 27, 2017, the Federal Circuit affirmed, in a split decision, a judgment by the Southern District of New York of the finding of inequitable conduct by Regeneron Pharmaceuticals (“Regeneron”) at least partially based on the conduct of Regeneron’s litigation attorneys during litigation.  Regeneron originally brought suit against Merus… read more

Case Analysis: Regeneron Pharmaceuticals, Inc. v. Merus N.V.

David W. Crosland, August 28, 2017

On July 27, 2017, the Federal Circuit affirmed, in a split decision, a judgment by the Southern District of New York of the finding of inequitable conduct by Regeneron Pharmaceuticals (“Regeneron”) at least partially based on the conduct of Regeneron’s litigation attorneys during litigation.  Regeneron originally brought suit against Merus… read more

Read more >